By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


HPV screening trial recommended

Cervical disease screening came under scrutiny when the UK National Screening Committee met last month.

The committee recommended trialling HPV testing as the primary screen for cervical disease as opposed to smear tests.

A pilot would aim to see whether the use of HPV testing leads to better outcomes for women, while minimising over-treatment and anxiety and examining how practical it would be to roll out on a national scale.

Such a scheme would be developed by the NHS Cervical Screening Programme.

National Screening Committee director Dr Anne Mackie said: “Part of the remit of the UK NSC is to look at how new tests, of proven effectiveness, can best be introduced to existing programmes.

“This is a good example of a new approach that could further improve an already successful screening programme. HPV testing may better indicate which women are at risk of cervical cancer”.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!